My NCBI | Sign In
RSS Settings
  • Search: Clotet Bonaventura[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 243

    1.

    HIV-1 Infection in Subjects Older than 70: A Multicenter Cross-Sectional Assessment in Catalonia, Spain.

    Mothe B, Perez I, Domingo P, Podzamczer D, Ribera E, Curran A, Viladés C, Vidal F, Dalmau D, Pedrol E, Negredo E, Moltó J, Paredes R, Perez-Alvarez N, Gatell JM, Clotet B.

    Curr HIV Res. 2009 Nov;7(6):597-600.PMID: 19929794 [PubMed - in process]

    2.

    Long-term effectiveness and safety outcomes in HIV-1-infected patients after a median time of 6 years on nevirapine.

    Rodríguez-Arrondo F, Aguirrebengoa K, Portu J, Muñoz J, García MA, Goikoetxea J, Martínez E, Iribarren JA, Perez-Alvarez N, Negredo E, Clotet B.

    Curr HIV Res. 2009 Sep;7(5):526-32.PMID: 19925403 [PubMed - in process]Related articles

    3.

    Increased peripheral proinflammatory cytokines in HIV-1-infected patients with prolonged viral suppression suffering from high psychological stress.

    Fumaz CR, Gonzalez-Garcia M, Borras X, Ferrer MJ, Muñoz-Moreno JA, Peña R, Perez-Alvarez N, Puig J, Paredes R, Fernandez-Castro J, Clotet B.

    J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):427-8. No abstract available. PMID: 19858924 [PubMed - indexed for MEDLINE]Related articles

    4.

    Transmission of drug-resistant HIV-1 is stabilizing in Europe.

    Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, Hamouda O, Kücherer C, Struck D, Schmit JC, Asjö B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A, Korn K, Kostrikis L, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Riva C, Ruiz L, Salminen M, Schuurman R, Sonnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher CA.

    J Infect Dis. 2009 Nov 15;200(10):1503-8.PMID: 19835478 [PubMed - indexed for MEDLINE]Related articles

    5.

    On the steps of cell-to-cell HIV transmission between CD4 T cells.

    Puigdomènech I, Massanella M, Cabrera C, Clotet B, Blanco J.

    Retrovirology. 2009 Oct 13;6:89.PMID: 19825175 [PubMed - in process]Related articlesFree article

    6.

    Clinical management of HIV-1 resistance.

    Paredes R, Clotet B.

    Antiviral Res. 2009 Oct 4. [Epub ahead of print]PMID: 19808056 [PubMed - as supplied by publisher]Related articles

    7.

    The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates.

    Buzón MJ, Dalmau J, Puertas MC, Puig J, Clotet B, Martinez-Picado J.

    AIDS. 2009 Sep 16. [Epub ahead of print]PMID: 19770695 [PubMed - as supplied by publisher]Related articles

    8.

    Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients.

    Pérez-Elías MJ, Gatell JM, Flores J, Santos J, Vera-Médez F, Clotet B, Moreno A, Pérez-Molina JA, Vendrell B, Serrano O.

    HIV Clin Trials. 2009 Jul-Aug;10(4):269-75.PMID: 19723614 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment.

    Pérez-Elías MJ, Morellon ML, Ortega E, Hernández-Quero J, Rodríguez-Torres M, Clotet B, Felizarta F, Gutiérrez F, Pineda JA, Nichols G, Lou Y, Wire MB.

    Antimicrob Agents Chemother. 2009 Dec;53(12):5185-96. Epub 2009 Aug 10.PMID: 19667283 [PubMed - in process]Related articles

    10.

    Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

    Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B; MULTINEKA Study Group.

    Clin Infect Dis. 2009 Sep 15;49(6):892-900.PMID: 19663689 [PubMed - indexed for MEDLINE]Related articles

    11.

    Unboosted atazanavir plus co-formulated lamivudine/abacavir as a ritonavir-sparing simplification strategy in routine clinical practice.

    Santos JR, Moltó J, Llibre JM, Pérez N, Capitán, Miranda C, Clotet B.

    HIV Clin Trials. 2009 May-Jun;10(3):129-34.PMID: 19632951 [PubMed - indexed for MEDLINE]Related articles

    12.

    Epistasis among deleterious mutations in the HIV-1 protease.

    Parera M, Perez-Alvarez N, Clotet B, Martínez MA.

    J Mol Biol. 2009 Sep 18;392(2):243-50. Epub 2009 Jul 14.PMID: 19607838 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settings.

    Cozzi-Lepri A, Phillips AN, Martinez-Picado J, Monforte A, Katlama C, Eg Hansen AB, Horban A, Bruun J, Clotet B, Lundgren JD; EuroSIDA Study Group.

    J Infect Dis. 2009 Sep 1;200(5):687-97.PMID: 19604043 [PubMed - indexed for MEDLINE]Related articles

    14.

    The changing face of HIV/AIDS in treated patients.

    Llibre JM, Falco V, Tural C, Negredo E, Pineda JA, Muñoz J, Ortega E, Videla S, Sirera G, Martinez E, Miralles C, Iribarren J, Galindo MJ, Domingo P, d'Arminio-Monforte A, Miro JM, Clotet B.

    Curr HIV Res. 2009 Jul;7(4):365-77. Review.PMID: 19601771 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Lopinavir/ritonavir monotherapy as a simplification strategy in antiretroviral therapy in clinical practice]

    Moltó J, Clotet B.

    Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 16:24-6. Review. Spanish. PMID: 19572441 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lymphogranuloma venerium proctitis in the setting of HIV: a case report and differential diagnosis.

    Heras E, Llibre JM, Sirera G, Mate JL, Boix V, Rey-Joly C, Clotet B.

    AIDS Patient Care STDS. 2009 Jul;23(7):493-4. No abstract available. PMID: 19534601 [PubMed - indexed for MEDLINE]Related articles

    17.

    Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.

    Muñoz-Moreno JA, Fumaz CR, Ferrer MJ, González-García M, Moltó J, Negredo E, Clotet B.

    AIDS Rev. 2009 Apr-Jun;11(2):103-9. Review.PMID: 19529750 [PubMed - indexed for MEDLINE]Related articles

    18.

    Low levels of adherence to antiretroviral therapy in HIV-1-infected women with menstrual disorders.

    Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, Negredo E, Pérez-Alvarez N, Tarrats A, Clotet B.

    AIDS Patient Care STDS. 2009 Jun;23(6):463-8.PMID: 19519230 [PubMed - indexed for MEDLINE]Related articles

    19.

    HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection.

    Clotet-Codina I, Bosch B, Senserrich J, Fernández-Figueras MT, Peña R, Ballana E, Bofill M, Clotet B, Esté JA.

    Antiviral Res. 2009 Jul;83(1):94-8. Epub 2009 Apr 5.PMID: 19501262 [PubMed - indexed for MEDLINE]Related articles

    20.

    A step ahead on the HIV collaboratory.

    Murphy RL, Autran B, Katlama C, Brucker G, Debre P, Calvez V, Clotet B, Clumeck N, Costagliola D, Deeks SG, Dorrell L, Gatell J, Haase A, Klein M, Lazzarin A, McMichael AJ, Papagno L, Schacker TW, Wain-Hobson S, Walker BD, Youle M.

    Science. 2009 Jun 5;324(5932):1264-5. No abstract available. PMID: 19498149 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    28 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity